Trivalent Ganglioside Vaccine With Immunological Adjuvant or Immunological Adjuvant Alone in Metastatic Sarcoma Patients Who Are Rendered Disease Free
Clinical trial NCT01141491 · COMPLETED
Trial details
- NCT number
- NCT01141491
- Sponsor
- MabVax Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2013-09-01
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.